2021
DOI: 10.18295/squmj.6.2021.096
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Aspergillus and Mucor Co-Infection

Abstract: Co-infections or consecutive infections of mucormycosis and aspergillosis are very rare. Additionally, distinguishing between these two infections is also difficult as both these conditions have similar clinical features. We report two similar cases from Tamilnadu, who presented to a tertiary care centre in Puducherry, India in 2017 (first case) and 2019 (second case).The first case was a 70-year-old, non-diabetic male patient who presented with haemoptysis with a prior history of pulmonary tuberculosis. Compu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…While our patients and several of those presented in Table 1 were immunosuppressed as treatment for hematologic malignancy or organ transplantation, Patients 5 and 7 suffered from autoimmune diseases. In reviewing the literature, many patients with diabetes mellitus, chronic steroid use for rheumatologic diseases, and short-term use of high-dose steroids to treat SARS-CoV-2 in otherwise immunocompetent patients were found to experience fungal coinfection [ 11 , 12 , 13 ]. While these cases were not included due to lack of autopsy results, they indicate that fungal coinfection is not uncommon and impacts a broad patient population.…”
Section: Discussionmentioning
confidence: 99%
“…While our patients and several of those presented in Table 1 were immunosuppressed as treatment for hematologic malignancy or organ transplantation, Patients 5 and 7 suffered from autoimmune diseases. In reviewing the literature, many patients with diabetes mellitus, chronic steroid use for rheumatologic diseases, and short-term use of high-dose steroids to treat SARS-CoV-2 in otherwise immunocompetent patients were found to experience fungal coinfection [ 11 , 12 , 13 ]. While these cases were not included due to lack of autopsy results, they indicate that fungal coinfection is not uncommon and impacts a broad patient population.…”
Section: Discussionmentioning
confidence: 99%
“…Coinfections or consecutive infections of Mucor and Aspergillosis are extremely rare and mainly observed in immunocompromised patients [5] . Here, we report a combination pulmonary infection with Mucor and Aspergillus in a diabetic girl.…”
Section: Introductionmentioning
confidence: 99%